Keyword: National Comprehensive Cancer Network
Adventist Health is using technology to streamline and scale its cancer risk assessment program to more effectively identify high-risk patients.
As doctors welcome the CDC’s clarification of its opioid guideline, the authors of that guideline say medical professionals had misapplied the recommendations.
Under pressure from healthcare experts, the CDC has clarified the controversial federal guideline for prescribing opioids.
The Food and Drug Administration needs access to more data as it rethinks what a clinical trial looks like, said Commissioner Scott Gottlieb.
In the rapidly advancing field of medical technology, progress often outpaces payment policy. Case in point: proton therapy for cancer patients.
